ConductScience.org, home

Paper1963290

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

Moreau NJ and 3 others. Antimicrob Agents Chemother, 1990. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Papers, record 1963290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1963290

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moreau NJN J
2Robaux HH
3Baron LL
4Tabary XX

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA Topoisomerases, Type IMajor topic
QuinolonesMajor topic
Topoisomerase II InhibitorsMajor topic
Animals
Cattle
DNA
Electrophoresis, Agar Gel
Escherichia coli
Microbial Sensitivity Tests
Plasmids
Thymus Gland

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16256766DNA gyrase on the bacterial chromosome: possibility of two levels of action.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6256766PubMed
22329555Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.J Med Chem1990https://conductscience.org/library/papers/2329555PubMed
36312258Escherichia coli DNA gyrase.Methods Enzymol1983https://conductscience.org/library/papers/6312258PubMed
46588970Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase.Biochem Biophys Res Commun1984https://conductscience.org/library/papers/6588970PubMed
56097803Biology of bacterial deoxyribonucleic acid topoisomerases.Microbiol Rev1984https://conductscience.org/library/papers/6097803PubMed
62982821Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.J Biol Chem1985https://conductscience.org/library/papers/2982821PubMed
72986908DNA topoisomerases: enzymes that control DNA conformation.Curr Top Microbiol Immunol1985https://conductscience.org/library/papers/2986908PubMed
82992360DNA topoisomerases.Annu Rev Biochem1985https://conductscience.org/library/papers/2992360PubMed
92997227Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.J Biol Chem1985https://conductscience.org/library/papers/2997227PubMed
103005575New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.J Med Chem1986https://conductscience.org/library/papers/3005575PubMed
113006754Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.Biochemistry1986https://conductscience.org/library/papers/3006754PubMed
123014661Tandem regions of yeast DNA topoisomerase II share homology with different subunits of bacterial gyrase.Science1986https://conductscience.org/library/papers/3014661PubMed
133015015Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3015015PubMed
143023077Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa.Eur J Biochem1986https://conductscience.org/library/papers/3023077PubMed
153026152Mechanistic aspects of DNA topoisomerases.Adv Protein Chem1986https://conductscience.org/library/papers/3026152PubMed
1636060764-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3606076PubMed
173606077Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3606077PubMed
182830840Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2830840PubMed
192831987Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.Biochim Biophys Acta1988https://conductscience.org/library/papers/2831987PubMed
203283179Mode of action, and in vitro and in vivo activities of the fluoroquinolones.J Clin Pharmacol1988https://conductscience.org/library/papers/3283179PubMed

See all 34 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
32630159Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity.Int J Mol Sci2020https://conductscience.org/library/papers/32630159PubMed
26695512A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.Curr Med Chem2016https://conductscience.org/library/papers/26695512PubMed
22155972Evaluating the genotoxicity of topoisomerase-targeted antibiotics.Mutagenesis2012https://conductscience.org/library/papers/22155972PubMed
21270840Coral-mucus-associated Vibrio integrons in the Great Barrier Reef: genomic hotspots for environmental adaptation.ISME J2011https://conductscience.org/library/papers/21270840PubMed
19042977Bacterial topoisomerase I as a target for discovery of antibacterial compounds.Nucleic Acids Res2009https://conductscience.org/library/papers/19042977PubMed
15517387The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.Parasitol Res2004https://conductscience.org/library/papers/15517387PubMed
9756776Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9756776PubMed
9293187DNA gyrase, topoisomerase IV, and the 4-quinolones.Microbiol Mol Biol Rev1997https://conductscience.org/library/papers/9293187PubMed
8878580Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8878580PubMed
8388196Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8388196PubMed
8257142
Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.
Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8257142PubMed
8192436New quinolones and gram-positive bacteria.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8192436PubMed
8109923A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potential.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8109923PubMed
7872758Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7872758PubMed
7859313Energy-dependent mitochondrial mutagenicity of antibacterial ofloxacin and its recombinogenic activity in yeast.Curr Genet1994https://conductscience.org/library/papers/7859313PubMed
7492087Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7492087PubMed
1666499Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1666499PubMed
1336340Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1336340PubMed
1323952Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1323952PubMed
1319844Ofloxacin induces cytoplasmic respiration-deficient mutants in yeast Saccharomyces cerevisiae.Curr Genet1992https://conductscience.org/library/papers/1319844PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1963290

GET https://conductscience.org/api/papers/v1/1963290/references?page=2